Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,033.65
-5.7053-0.28%
Number of Gainers:343
Number of Losers:659
Number of Flat:17
PE:- -
High:2,039.37
Open:2,039.37
Low:2,033.07
Close:2,039.36
Volume:1.32B
Turnover:168.81B
Market Cap:97.14T
Float Cap:90.93T

Loading ...

TÜV Rheinland Qualifies Fennec Engineering ASAP Tools as IEC 61508 T2 Support Tools

Reuters
·
Sep 22

Cybersecurity Awareness Week: Digital Learning Cornerstones Workplace Safety

Deep News
·
Sep 22

Rooted in Zhangjiang, Connected to the World: SH Pharma Powers an Open Innovation Ecosystem as an Ecosystem Anchor

Deep News
·
Sep 22

Synchrony Financial Schedules Third-Quarter Results Release and Conference Call

Reuters
·
Sep 22

Oracle Named a Leader in Idc Marketscape: Worldwide Life Sciences R&D

THOMSON REUTERS
·
Sep 22

Adagene Says China NMPA Clears IND for Adg138 HER2xCD3 Bispecific T-Cell Engager

Reuters
·
Sep 22

Factset - Announces Acquisition of Bcc Group International

THOMSON REUTERS
·
Sep 22

Factset - Acquisition not Expected to Materially Impact Factset's Financial Results

THOMSON REUTERS
·
Sep 22

Marist University and Ibm Launch Innovation Incubator with Ibm Z17, Expanding 50-Year Partnership to Advance AI Research and Student Career Readiness

THOMSON REUTERS
·
Sep 22

Oracle Partners with Wipro to Strengthen End-to-End Pharmacovigilance Services

THOMSON REUTERS
·
Sep 22

Oracle Named a Leader in the 2026 Gartner® Magic Quadrant™ for HCM Suites for 1,000+ Employee Enterprises

THOMSON REUTERS
·
Sep 22

Rhythm Pharmaceuticals Announces Health Canada Approval of Imcivree® (Setmelanotide) for Weight Management in Adult and Pediatric Patients 4 Years of Age and Older with Acquired Hypothalamic Obesity

THOMSON REUTERS
·
Sep 22

Vertex Pharmaceuticals Incorporated - Inaxaplin Generally Safe and Well Tolerated in Both Amkd Cohorts

THOMSON REUTERS
·
Sep 22

Lantheus Receives Final FDA Approval for Bravnetsa™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA Has Determined to be Bioequivalent and Therapeutically Equivalent to Lutathera® for the Treatment of Gep-Nets

THOMSON REUTERS
·
Sep 22

Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System

GlobeNewswire
·
Sep 22

PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology

GlobeNewswire
·
Sep 22

Press Release: Century Lithium Advances PLANS for CHLOR-Alkali PLANT

Dow Jones
·
Sep 22

Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies

GlobeNewswire
·
Sep 22

OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

GlobeNewswire
·
Sep 22

Breakingviews-Paramount’s M&A Win Seals Showbiz’s Hamilton Fever

Reuters
·
Sep 22